264936 Impact of health insurance-related policy changes on the incidence of late-stage breast cancer diagnoses in Oklahoma women diagnosed during 2000–2007

Monday, October 29, 2012

Amanda Janitz, MPH , Oklahoma Public Health Training Center, The University of Oklahoma Health Sciences Center, Oklahoma City, OK
Summer Frank, MPH , Department of Biostatistics and Epidemiology, The University of Oklahoma Health Sciences Center, Oklahoma City, OK
Angela Watkins, MBA, MPH , Community Epidemiology and Evaluation, Oklahoma State Department of Health, Oklahoma City, OK
Aaron Wendelboe, PhD , Department of Biostatistics and Epidemiology, The University of Oklahoma Health Sciences Center, Oklahoma City, OK
Janis Campbell, PhD , Department of Biostatistics and Epidemiology, The University of Oklahoma Health Sciences Center, Oklahoma City, OK
Background: In 2000, Congress passed the Breast and Cervical Cancer Prevention and Treatment Act (BCCPTA). We aimed to examine the impact of the BCCPTA on the incidence of late-stage breast cancer in women living in Oklahoma while controlling for other important factors, such as insurance status and the urbanicity of the woman's residence. Methods: Data were obtained from the Oklahoma Central Cancer Registry from 2000 to 2007. Analyses were performed on individual-level variables of race, age, insurance status, residential status, and timing related to the BCCPTA, and ecologic variables of federal poverty level and education level. We used descriptive statistics and logistic regression to analyze the relationship between the proportion of women diagnosed with late-stage breast cancer and the independent variables. Results: We found that the proportion of late-stage breast cancers in women were not different after compared to before the BCCPTA (OR: 1.05, 95% CI: 0.99, 1.12). Those with Medicaid (OR: 0.90, 95% CI: 0.73, 1.10) and uninsured (OR: 0.83, 95% CI: 0.58, 1.18) had a lower odds of being diagnosed with late-stage breast cancer after compared to before the BCCPTA, although this finding was not significant. Discussion: Oklahoma implemented the BCCPTA in a novel way and we looked at its implementation using high quality extant data. Although not significant, our findings show improved outcomes in women with Medicaid after the BCCPTA and in uninsured women. More years of follow-up data may be required to fully appreciate the effect the BCCPTA had in Oklahoma.

Learning Areas:
Chronic disease management and prevention
Conduct evaluation related to programs, research, and other areas of practice
Implementation of health education strategies, interventions and programs
Public health or related public policy

Learning Objectives:
1. Describe the effects of the BCCPTA in women with Medicaid and without insurance regarding late-stage breast cancer. 2. Name the unique aspect of Oklahoma’s implementation of the BCCPTA.

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I have been working with breast cancer data as a student and have been the primary authors analyzing the data. My scientific interests include the epidemiology of cancer.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.